These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 21810389)
21. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Korn JH; Mayes M; Matucci Cerinic M; Rainisio M; Pope J; Hachulla E; Rich E; Carpentier P; Molitor J; Seibold JR; Hsu V; Guillevin L; Chatterjee S; Peter HH; Coppock J; Herrick A; Merkel PA; Simms R; Denton CP; Furst D; Nguyen N; Gaitonde M; Black C Arthritis Rheum; 2004 Dec; 50(12):3985-93. PubMed ID: 15593188 [TBL] [Abstract][Full Text] [Related]
22. End stage renal disease caused by thromboangiitis obliterans: a case report. Yun HJ; Kim DI; Lee KH; Lim SJ; Hwang WM; Yun SR; Yoon SH J Med Case Rep; 2015 Aug; 9():174. PubMed ID: 26286269 [TBL] [Abstract][Full Text] [Related]
23. Bosentan as a rescue therapy in scleroderma refractory digital ulcers. Chamaillard M; Heliot-Hosten I; Constans J; Taïeb A Arch Dermatol; 2007 Jan; 143(1):125-6. PubMed ID: 17224564 [No Abstract] [Full Text] [Related]
24. A Non-smoking Woman with Anti-phospholipid Antibodies Proved to Have Thromboangiitis Obliterans. Shima N; Akiyama Y; Yamamoto S; Kokuzawa A; Nagatani K; Iwamoto M; Matsubara D; Kawai S; Sato K; Minota S Intern Med; 2020 Feb; 59(3):439-443. PubMed ID: 31588083 [TBL] [Abstract][Full Text] [Related]
25. Thromboangiitis obliterans with inaugural rheumatic manifestations. A report of three cases. Lambotte O; Chazerain P; Vinciguerra C; Meyer O; Ziza JM Rev Rhum Engl Ed; 1997 May; 64(5):334-8. PubMed ID: 9190007 [TBL] [Abstract][Full Text] [Related]
26. Thromboangiitis obliterans successfully treated with phosphodiesterase type 5 inhibitors. Abeles AM; Nicolescu M; Pinchover Z; Abeles M Vascular; 2014 Aug; 22(4):313-6. PubMed ID: 24000082 [TBL] [Abstract][Full Text] [Related]
27. Left Carotid Artery Thrombosis Due to Thromboangiitis Obliterans. Bourgeau ME; Key PG; Chou J; Prahlow JA Am J Forensic Med Pathol; 2021 Sep; 42(3):297-300. PubMed ID: 33346979 [TBL] [Abstract][Full Text] [Related]
28. Bosentan in clinical practice for treating digital and other ischemic ulcers in Spanish patients with systemic sclerosis: IBER-DU cohort study. Roman Ivorra JA; Simeon CP; Alegre Sancho JJ; Egurbide MV; Castillo MJ; Lloria X; Fonollosa V J Rheumatol; 2011 Aug; 38(8):1631-5. PubMed ID: 21632679 [TBL] [Abstract][Full Text] [Related]
29. Cerebral vein thrombosis in a case with thromboangiitis obliterans. Bischof F; Kuntz R; Melms A; Fetter M Cerebrovasc Dis; 1999; 9(5):295-7. PubMed ID: 10473913 [TBL] [Abstract][Full Text] [Related]
30. Intrarenal arterial stenosis in a patient with thromboangiitis obliterans. Goktas S; Bedir S; Bozlar U; Ilica AT; Seckin B Int J Urol; 2006 Sep; 13(9):1243-4. PubMed ID: 16984562 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling pansclerotic morphea in children. Roldan R; Morote G; Castro Mdel C; Miranda MD; Moreno JC; Collantes E J Rheumatol; 2006 Dec; 33(12):2538-40. PubMed ID: 17143989 [TBL] [Abstract][Full Text] [Related]
32. Substitution of smokeless tobacco for cigarettes in Buerger's disease does not prevent limb loss. Lawrence PF; Lund OI; Jimenez JC; Muttalib R J Vasc Surg; 2008 Jul; 48(1):210-2. PubMed ID: 18589234 [TBL] [Abstract][Full Text] [Related]